Health-Related Quality of Life in Lenalidomide and Bortezomib Treated Patients with Relapsed/Refractory Multiple Myeloma

被引：0
|
作者：
Kyriakou, Charalampia [1 ,2 ]
Murphy, Philip [3 ]
Petrucci, Maria Teresa [4 ]
Bacon, Pamela [5 ]
Lewis, Philip [6 ]
Gilet, Helene [7 ]
Arnould, Benoit [7 ]
Vande Broek, Isabelle [8 ]
Leleu, Xavier [9 ]
机构：
[1] Royal Free Hosp, Dept Haematol, London NW3 2QG, England
[2] Northwick Pk Hosp & Clin Res Ctr, Dept Haematol, London NW3 2QG, England
[3] Beaumont Hosp, Dublin 9, Ireland
[4] Univ Roma La Sapienza, Div Hematol, Dept Cellular Biotechnol & Hematol, I-00185 Rome, Italy
[5] Celgene Int Sarl, Boudry, Switzerland
[6] Celgene GmbH, Munich, Germany
[7] Mapi, Lyon, France
[8] Iridium Kankernetwerk, St Niklaas, Belgium
[9] Hop Claude Huriez, CHRU, Lille, France
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Health-Related Quality of Life With Pomalidomide plus Dexamethasone plus Daratumumab After Lenalidomide in Relapsed or Refractory Multiple Myeloma Patients
    Reece, Donna
    Bahlis, Nizar J.
    Samaras, Christy Joy
    Sebag, Michael
    Berdeja, Jesus
    Ganguly, Siddhartha
    Matous, Jeffrey
    Song, Kevin
    Seet, Christopher S.
    Talamo, Giampaolo
    Acosta-Rivera, Mirelis
    Bar, Michael
    Quick, Donald
    Anz, Bertrand
    Fonseca, Gustavo
    Agarwal, Amit
    Chung, Weiyuan
    Zafar, Faiza
    Siegel, David S.
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E277 - E278
  • [2] Health-related quality of life with idecabtagene vicleucel in relapsed and refractory multiple myeloma
    Delforge, Michel
    Shah, Nina
    Miguel, Jesus San F.
    Braverman, Julia
    Dhanda, Devender S.
    Shi, Ling
    Guo, Shien
    Yu, Peiwen
    Liao, Weiqin
    Campbell, Timothy B.
    Munshi, Nikhil C.
    [J]. BLOOD ADVANCES, 2022, 6 (04) : 1309 - 1318
  • [3] Health-related quality of life in patients with relapsed or refractory multiple myeloma: treatment with daratumumab, lenalidomide, and dexamethasone in the phase 3 POLLUX trial
    Plesner, Torben
    Dimopoulos, Meletios A.
    Oriol, Albert
    San-Miguel, Jesus
    Bahlis, Nizar J.
    Rabin, Neil
    Suzuki, Kenshi
    Yoon, Sung-Soo
    Ben-Yehuda, Dina
    Cook, Gordon
    Goldschmidt, Hartmut
    Grosicki, Sebastian
    Qin, Xiang
    Fastenau, John
    Garvin, Wendy
    Carson, Robin
    Renaud, Thomas
    Gries, Katharine S.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2021, 194 (01) : 132 - 139
  • [4] Successful retreatment with lenalidomide for relapsed and refractory multiple myeloma previously treated with bortezomib, lenalidomide and pomalidomide
    Oka, Satoko
    Ono, Kazuo
    Nohgawa, Masaharu
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2018, 43 (06) : 914 - 917
  • [5] Health-related quality of life outcomes in relapsed and/or refractory multiple myeloma: a systematic review
    Sparano, Francesco
    Cavo, Michele
    Niscola, Pasquale
    Efficace, Fabio
    [J]. QUALITY OF LIFE RESEARCH, 2016, 25 : 123 - 124
  • [6] Health-related quality of life outcomes from the CANDOR study in patients with relapsed or refractory multiple myeloma
    Siegel, David
    Weisel, Katja
    Zahlten-Kumeli, Anita
    Medhekar, Rohan
    Ding, Bifeng
    Leleu, Xavier
    [J]. LEUKEMIA & LYMPHOMA, 2021, 62 (12) : 3002 - 3010
  • [7] Patient Perspectives on Treatment Experience and Health-Related Quality of Life in Patients with Relapsed/Refractory Multiple Myeloma
    Nathwani, Nitya
    Bell, Jill A.
    Cherepanov, Dasha
    Sowell, France Ginchereau
    Shah, Rachel
    McCarrier, Kelly
    Hari, Parameswaran
    [J]. BLOOD, 2020, 136
  • [8] COMPARISON OF PATIENTS' AND PHYSICIANS' PERCEPTIONS OF PATIENTS' BASELINE HEALTH-RELATED QUALITY OF LIFE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA
    Broek, I.
    Murphy, P.
    Petrucci, M.
    Kyriakou, C.
    Welslau, M.
    Bacon, P.
    Lewis, P.
    Gilet, H.
    Arnould, B.
    Bottomley, A.
    Leleu, X.
    [J]. HAEMATOLOGICA, 2013, 98 : 443 - 443
  • [9] LONGITUDINAL COMPARISON OF PATIENTS' AND PHYSICIANS' PERCEPTIONS OF PATIENTS' HEALTH-RELATED QUALITY OF LIFE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA
    Vande Broek, I.
    Petrucci, M. T.
    Leleu, X.
    Murphy, P.
    Welslau, M.
    Bacon, P.
    Lewis, P.
    Gilet, H.
    Arnould, B.
    Kyriakou, C.
    [J]. HAEMATOLOGICA, 2014, 99 : 368 - 368
  • [10] Pomalidomide, bortezomib, and dexamethasone for patients with relapsed lenalidomide-refractory multiple myeloma
    Paludo, Jonas
    Mikhael, Joseph R.
    LaPlant, Betsy R.
    Halvorson, Alese E.
    Kumar, Shaji
    Gertz, Morie A.
    Hayman, Suzanne R.
    Buadi, Francis K.
    Dispenzieri, Angela
    Lust, John A.
    Kapoor, Prashant
    Leung, Nelson
    Russell, Stephen J.
    Dingli, David
    Go, Ronald S.
    Lin, Yi
    Gonsalves, Wilson I.
    Fonseca, Rafael
    Bergsagel, P. Leif
    Roy, Vivek
    Sher, Taimur
    Chanan-Khan, Asher A.
    Ailawadhi, Sikander
    Stewart, A. Keith
    Reeder, Craig B.
    Richardson, Paul G.
    Rajkumar, S. Vincent
    Lacy, Martha Q.
    [J]. BLOOD, 2017, 130 (10) : 1198 - 1204
12345